Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Cognetivity Neurosciences Ltd

Healthcare US CGNSF

0.0001USD
0.00(0%)

Last update at 2026-06-18T13:30:00Z

Day Range

0.00010.0001
LowHigh

52 Week Range

0.00010.0019
LowHigh

Fundamentals

  • Previous Close 0.0001
  • Market Cap0.00896M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-4.23230M
  • Revenue TTM0.10M
  • Revenue Per Share TTM0.001
  • Gross Profit TTM -1.26555M
  • Diluted EPS TTM-0.06

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-01-31 2022-01-31 2021-01-31 2020-01-31 2019-01-31
Type yearly yearly yearly yearly yearly
Date 2023-01-31 2022-01-31 2021-01-31 2020-01-31 2019-01-31
Income before tax -7.43382M -13.12733M -1.92581M -2.66029M -4.19262M
Minority interest - - - - 0.00000M
Net income -7.43382M -13.12733M -1.92810M -2.64511M -4.19262M
Selling general administrative 5.61M 12.54M 2.38M 2.10M 3.48M
Selling and marketing expenses - - - - -
Gross profit - - - - -0.32541M
Reconciled depreciation 0.02M 0.02M 0.01M 0.00929M 0.00394M
Ebit - -13.00382M -2.40472M -2.54347M -4.09079M
Ebitda -6.38170M -13.04225M -1.85153M -2.59502M -4.20836M
Depreciation and amortization - - - - -
Non operating income net other - - - - 0.00000M
Operating income -6.39040M -13.05746M -2.45769M -2.60558M -4.21230M
Other operating expenses - - - - 0.00000M
Interest expense 1.03M 0.06M 0.06M 0.06M 0.00000M
Tax provision 0.00000M 0.00000M 0.00229M -0.01517M -
Interest income - - - - 0.02M
Net interest income -1.02748M -0.06055M -0.06284M -0.05597M 0.02M
Extraordinary items - - - - 0.00000M
Non recurring - - - - 0.00000M
Other items - - - - 0.00000M
Income tax expense - - 0.00229M -0.01517M 0.00000M
Total revenue 0.05M 0.00000M 0.00000M 0.00000M 0.00000M
Total operating expenses 6.44M 13.06M 2.46M 2.61M 4.21M
Cost of revenue - - - - 0.33M
Total other income expense net -0.01593M -0.00931M 0.59M 0.00127M -0.00171M
Discontinued operations - - - - 0.00000M
Net income from continuing ops -7.43382M -13.12733M -1.92810M -2.64511M -4.19262M
Net income applicable to common shares - -13.12733M -1.92810M -2.64511M -4.19262M
Preferred stock and other adjustments - - - - 0.00000M
Breakdown 2023-01-31 2022-01-31 2021-01-31 2020-01-31 2019-01-31
Type yearly yearly yearly yearly yearly
Date 2023-01-31 2022-01-31 2021-01-31 2020-01-31 2019-01-31
Total assets 2.83M 2.00M 1.83M 0.75M 0.72M
Intangible assets 0.11M 0.09M 0.03M - 0.00000M
Earning assets - - - - -
Other current assets - - - - 0.00000M
Total liab 12.72M 7.68M 0.96M 1.01M 0.24M
Total stockholder equity -9.88954M -5.67538M 0.86M -0.26304M 0.48M
Deferred long term liab - - - - 0.00000M
Other current liab 5.54M 0.15M 0.01M - 0.02M
Common stock - 12.88M 9.87M 7.03M 5.18M
Capital stock 15.67M 12.88M 9.87M 7.03M 5.18M
Retained earnings -31.39867M -23.96486M -10.83753M -8.90943M -6.26432M
Other liab - 2.12M - - 0.00000M
Good will - - - - 0.00000M
Other assets - - - - 0.00000M
Cash 2.24M 1.38M 1.36M 0.58M 0.25M
Cash and equivalents - - - - -
Total current liabilities 10.59M 5.56M 0.96M 1.01M 0.24M
Current deferred revenue - - - - -
Net debt - - - - -
Short term debt - - - - 0.00000M
Short long term debt 1.29M 1.29M 0.31M 0.31M 0.00000M
Short long term debt total - - - - -
Other stockholder equity - 5.41M 1.83M 1.62M 1.56M
Property plant equipment - 0.06M 0.04M 0.04M 0.03M
Total current assets 2.66M 1.86M 1.75M 0.71M 0.69M
Long term investments - - - - 0.00000M
Net tangible assets - -5.76070M 0.83M -0.26304M 0.48M
Short term investments - - - 0.00000M 0.13M
Net receivables 0.14M 0.43M 0.08M 0.05M 0.20M
Long term debt - - - - 0.00000M
Inventory - - - - 0.00000M
Accounts payable 2.12M 0.99M 0.64M 0.63M 0.22M
Total permanent equity - - - - 0.00000M
Noncontrolling interest in consolidated entity - - - - 0.00000M
Temporary equity redeemable noncontrolling interests - - - - 0.00000M
Accumulated other comprehensive income - - - - 0.00000M
Additional paid in capital - - - - 0.00000M
Common stock total equity - - - - 0.00000M
Preferred stock total equity - - - - 0.00000M
Retained earnings total equity - - - - 0.00000M
Treasury stock - - - - 0.00000M
Accumulated amortization - - - - 0.00000M
Non currrent assets other - - - - 0.03M
Deferred long term asset charges - - - - 0.00000M
Non current assets total 0.17M 0.15M 0.08M 0.04M 0.03M
Capital lease obligations - - - - 0.00000M
Long term debt total - - - - 0.00000M
Breakdown 2023-01-31 2022-01-31 2021-01-31 2020-01-31 2019-01-31
Type yearly yearly yearly yearly yearly
Date 2023-01-31 2022-01-31 2021-01-31 2020-01-31 2019-01-31
Investments -0.06968M -0.10001M -0.05008M 0.13M 3.34M
Change to liabilities 0.00000M 1.31M 0.14M 0.52M -0.10877M
Total cashflows from investing activities - -0.10001M -0.05008M 0.11M 3.32M
Net borrowings - 1.27M 1.27M 0.33M 0.33M
Total cash from financing activities 6.88M 3.33M 2.79M 2.08M 0.30M
Change to operating activities -1.59047M 4.78M -0.31786M 0.23M -0.14056M
Net income -7.43382M -13.12733M -1.92810M -2.64511M -4.19262M
Change in cash 0.87M 0.02M 0.78M 0.33M 0.11M
Begin period cash flow 1.38M 1.36M 0.58M 0.25M 0.14M
End period cash flow 2.24M 1.38M 1.36M 0.58M 0.25M
Total cash from operating activities -5.94235M -3.21453M -1.95874M -1.85660M -3.48922M
Issuance of capital stock 6.88M 1.27M 2.54M 1.63M -
Depreciation 0.02M 0.02M 0.01M 0.00929M 0.00394M
Other cashflows from investing activities - - - - 0.00000M
Dividends paid - - - - 0.00000M
Change to inventory - - - - 0.00000M
Change to account receivables 0.06M -0.14831M -0.14831M -0.14831M 0.00000M
Sale purchase of stock - - - - 0.00000M
Other cashflows from financing activities - - 0.17M 0.17M 0.17M
Change to netincome - 3.94M 0.13M 0.03M 0.95M
Capital expenditures 0.07M 0.06M 0.02M 0.02M 0.02M
Change receivables - - - - 0.00000M
Cash flows other operating - - - - 0.00000M
Exchange rate changes - - - - 0.00000M
Cash and cash equivalents changes - - - - 0.00000M
Change in working capital 0.20M 5.95M -0.17398M 0.75M -0.24933M
Stock based compensation 0.56M 3.68M 0.08M 0.01M -
Other non cash items 0.94M 0.32M 0.08M 0.03M 0.08M
Free cash flow -6.01204M -3.31454M -2.00882M -1.87843M -3.51180M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CGNSF
Cognetivity Neurosciences Ltd		 - -% 0.0001 - 35.09 0.09 189.01 13.78 -2.0484
VEEV
Veeva Systems Inc Class A		 -0.61 0.40% 152.69 54.61 33.22 12.83 6.73 11.14 58.84
MTHRF
M3 Inc		 - -% 8.55 29.72 25.00 0.05 4.38 0.04 0.12
MTHRY
M3 Inc		 0.17 3.38% 5.20 31.84 26.25 0.05 4.60 0.04 0.12
BTSG
BrightSpring Health Services, Inc. Common Stock		 0.96 1.46% 67.22 100.22 40.65 0.69 4.92 0.92 25.80

Reports Covered

Stock Research & News

View All

Profile

Cognetivity Neurosciences Ltd. operates as a technology company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that allows early diagnosis of dementia; and OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada.

Cognetivity Neurosciences Ltd

1055 West Hastings Street, Vancouver, BC, Canada, V6E 2E9

Key Executives

Name Title Year Born
Dr. Sina Habibi Co-Founder, CEO & Director NA
Dr. Seyed-Mahdi Khaligh-Razavi Co-Founder & Chief Scientific Officer NA
Dr. Thomas Roger Sawyer M.B.A., Ph.D. COO, CFO, Company Sec. & Director 1970
Mr. Desmond M. Balakrishnan B.A., BA, L.L.B., LL.B. Legal Counsel & Director 1971
Dr. Christos Kalafatis Chief Medical Officer & Director NA
Mr. Jonathan El-Sharkawy Chief Technology Officer NA
Dr. Seyed-Mahdi Khaligh-Razavi Co-Founder & CIO NA
Dr. Thomas Roger Sawyer M.B.A., Ph.D. CFO, Company Secretary & Director 1970
Mr. Desmond M. Balakrishnan B.A., L.L.B. Legal Counsel & Director 1971

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.